| Adicet Aims to Advance CAR-T Therapies in Reverse Merger with resTORbio | Sarah de Crescenzo | 04/29/20 | Boston |
| Organovo Future Unclear After Shareholders Reject Tarveda Merger | Sarah de Crescenzo | 04/08/20 | San Diego |
| Histogen, Timber Pharma Plan Reverse Mergers to Join Public Markets | Sarah de Crescenzo | 01/28/20 | San Diego |
| VMWare Plans to Acquire Bitfusion for Application-Enhancing Software | David Holley | 07/18/19 | Texas |
| Oncternal Therapeutics Goes Public After Reverse Merger With GTx | Sarah de Crescenzo | 06/12/19 | San Diego |
| Dell Sets Return to Public Market With Shareholder OK of VMware Deal | David Holley | 12/11/18 | Texas |
| OncoMed’s Saga Ends in Reverse Merger with UK-Based Mereo BioPharma | Frank Vinluan | 12/05/18 | San Francisco |
| VMware Acquiring Cloud Analytics and Management Startup CloudHealth | David Holley | 08/27/18 | San Francisco |
| Millendo Therapeutics Goes Public With OvaScience Reverse Merger | David Holley | 08/09/18 | Detroit Ann Arbor |
| Hype―and Skepticism―Remains for Dell’s Return to the Public Market | David Holley | 07/10/18 | Texas |
| Futures Command, HeatGenie, Techstars Impact, UH & More TX Tech | Angela Shah | 06/07/18 | Texas |
| Aravive Seeks Nasdaq Perch Via Reverse Merger With Biotech Versartis | Angela Shah | 06/04/18 | Texas |
| New Silverton Fund, Brunner to Phunware, HEB Adds CDO & More TX Tech | Angela Shah | 05/22/18 | Texas |
| TX Tech: Phunware Goes Public, Biden at SXSW, BioHouston, & More | Angela Shah | 03/05/18 | Texas |
| Dell Reportedly Mulling a VMware Reverse Merger: What Could It Mean? | David Holley | 01/29/18 | Texas |
| Xconomy Q&A: An Update with Arcturus Therapeutics CEO Joseph Payne | Bruce V. Bigelow | 10/23/17 | San Diego |
| Five Questions For … Austin Biotech Entrepreneur Paul Lammers | Angela Shah | 09/29/17 | Texas |
| Austin’s Apollo Endosurgery Responds to FDA Note After Patient Deaths | Angela Shah | 08/21/17 | Texas |
| Houston Biotech Oncolix Announces Reverse Merger, Goes Public | Angela Shah | 08/07/17 | Texas |
| Acer Therapeutics Announces Reverse Merger With Houston’s Opexa | Angela Shah | 07/05/17 | Texas |
| Synlogic and Its Modified Bacteria Take Over Dying Company, Go Public | Alex Lash | 05/16/17 | Boston |
| Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More | Alex Lash | 09/02/16 | National |
| Leap Therapeutics Seeks Public Markets With Macrocure Merger | David Holley | 08/29/16 | Boston |
| After Reinvention, Pulmatrix Wraps Up Ruthigen Deal, Heads to Nasdaq | Ben Fidler | 06/16/15 | Boston |
| West Coast Biotech Roundup: Adaptive, Gilead, Juno, aTyr & More | Alex Lash | 05/08/15 | Boston |
| Organovo CEO: Closing IPO Window Could Spur More Reverse Mergers | Jeff Bauter Engel | 10/24/14 | Wisconsin |
| Biotech Startups Tap Spider Genes in Quest to Spin Silk Gold | Angela Shah | 10/14/14 | Raleigh Durham |
| A Few Raindrops Amid Texas Biotech IPO Drought | Angela Shah | 05/30/14 | Texas |
| Wizard World Jumps Off Printed Page and Into Digital Age | João-Pierre S. Ruth | 09/19/11 | New York |
| Looking for an Exit: Startup Founders, Investors, and Bankers Offer Some IPO Guidance | Bruce V. Bigelow | 06/02/10 | San Diego |
